Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Calcury
- Development stage
- Unknown
- Lead developer
- Charak
- Administration
- Oral
01
Overview
Calcury is a proprietary Ayurvedic polyherbal formulation developed by Charak Pharma for the management of urinary calculi (urolithiasis/kidney stones) and related urinary tract disorders. It is available in both tablet and syrup forms. The formulation contains a blend of traditional herbs, including *Crataeva nurvala* (Varuna), *Tribulus terrestris* (Gokshura), *Bergenia ligulata* (Pashanabheda), and *Boerhavia diffusa* (Punarnava), which collectively exhibit litholytic (stone-disintegrating), diuretic, anti-inflammatory, and analgesic properties. Calcury helps facilitate the passage of urinary stones, prevents their recurrence, maintains crystalloid-colloid balance, and relieves symptoms such as dysuria, hematuria, and renal colic.
- Brand names
- CalcuryCalcury SyrupCalcury Tablet
Beyond the preview
Go deeper on Calcury.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Calcury.